141 related articles for article (PubMed ID: 7525311)
1. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines.
Wang EC; Lehner PJ; Graham S; Borysiewicz LK
Eur J Immunol; 1994 Nov; 24(11):2903-9. PubMed ID: 7525311
[TBL] [Abstract][Full Text] [Related]
2. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
[TBL] [Abstract][Full Text] [Related]
3. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines.
Fishwild DM; Benike CJ; Engleman EG
J Immunol; 1988 Mar; 140(6):1994-8. PubMed ID: 2831276
[TBL] [Abstract][Full Text] [Related]
4. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.
van Binnendijk RS; Poelen MC; Kuijpers KC; Osterhaus AD; Uytdehaag FG
J Immunol; 1990 Mar; 144(6):2394-9. PubMed ID: 2107259
[TBL] [Abstract][Full Text] [Related]
5. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
[TBL] [Abstract][Full Text] [Related]
6. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes.
Bourgault I; Gomez A; Gomard E; Levy JP
Clin Exp Immunol; 1991 Jun; 84(3):501-7. PubMed ID: 1646086
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
Moss DJ; Misko IS; Burrows SR; Burman K; McCarthy R; Sculley TB
Nature; 1988 Feb; 331(6158):719-21. PubMed ID: 2830541
[TBL] [Abstract][Full Text] [Related]
8. Abnormally expanded CD8+/Leu-7+ lymphocytes persisting in long-term bone marrow-transplanted patients are resting pre-cytotoxic T-lymphocytes.
Leroy E; Madariaga L; Ben Aribia M; Mishal Z; Theodorou I; Rochant H; Vernant JP; Senik A
Exp Hematol; 1990 Aug; 18(7):770-4. PubMed ID: 1696205
[TBL] [Abstract][Full Text] [Related]
9. A lectin-binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity.
Sadat-Sowti B; Debré P; Idziorek T; Guillon JM; Hadida F; Okzenhendler E; Katlama C; Mayaud C; Autran B
Eur J Immunol; 1991 Mar; 21(3):737-41. PubMed ID: 1707006
[TBL] [Abstract][Full Text] [Related]
10. The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells.
Gouttefangeas C; Mansur I; Schmid M; Dastot H; Gélin C; Mahouy G; Boumsell L; Bensussan A
Eur J Immunol; 1992 Oct; 22(10):2681-5. PubMed ID: 1396972
[TBL] [Abstract][Full Text] [Related]
11. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K
Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323
[TBL] [Abstract][Full Text] [Related]
12. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
13. CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis.
Ebihara T; Sakai N; Koyama S
Tohoku J Exp Med; 1990 Nov; 162(3):213-24. PubMed ID: 1965352
[TBL] [Abstract][Full Text] [Related]
14. Antigens recognized on a melanoma cell line by autologous cytolytic T lymphocytes are also expressed on freshly collected tumor cells.
Degiovanni G; Hainaut P; Lahaye T; Weynants P; Boon T
Eur J Immunol; 1990 Aug; 20(8):1865-8. PubMed ID: 2209693
[TBL] [Abstract][Full Text] [Related]
15. Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitro.
Schmidt C; Burrows SR; Moss DJ; Sculley TB; Misko IS
Scand J Immunol; 1991 Apr; 33(4):411-20. PubMed ID: 1708166
[TBL] [Abstract][Full Text] [Related]
16. Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursors.
Man S; Lechler RI; Batchelor JR; Sharrock CE
Eur J Immunol; 1990 Apr; 20(4):847-54. PubMed ID: 2112094
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of lymphocytes by allogeneic lymphocytes and lymphoblasts in the presence of anti-HLA antisera.
Corley RB; Dawson JR; Amos DB
Eur J Immunol; 1976 Apr; 6(4):235-40. PubMed ID: 186270
[TBL] [Abstract][Full Text] [Related]
18. Changes of immunological patterns of human cancer cells treated in vitro with a triazene compound.
D'Atri S; Ballerini P; Fuggetta MP; Faggioni A; Piazza A; Giuliani A
Immunopharmacol Immunotoxicol; 1989; 11(1):101-18. PubMed ID: 2547862
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the in vitro generation of class II-restricted, HSV-1-specific, CD4+ CTL by HIV-1.
Mawle AC; Thieme ML; Ridgeway MR; McDougal JS; Schmid DS
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):229-41. PubMed ID: 2158337
[TBL] [Abstract][Full Text] [Related]
20. Induction of minor histocompatibility antigen-specific T-helper but not T-cytotoxic response is dependent on the source of antigen-presenting cell.
van Els CA; Bakker A; van Rood JJ; Goulmy E
Hum Immunol; 1990 May; 28(1):39-50. PubMed ID: 2160446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
